KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Taxes: 2010-2019

Historic Change in Taxes for Arbutus Biopharma (ABUS) over the last 2 years, with Mar 2019 value amounting to -$98,000.

  • Arbutus Biopharma's Change in Taxes fell 5000.00% to -$98,000 in Q1 2019 from the same period last year, while for Mar 2019 it was $192,000, marking a year-over-year increase of 236.84%. This contributed to the annual value of $49,000 for FY2018, which is 54.63% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Change in Taxes of -$98,000 as of Q1 2019, which was down 308.51% from $47,000 recorded in Q4 2018.
  • Arbutus Biopharma's Change in Taxes' 5-year high stood at $241,000 during Q4 2017, with a 5-year trough of -$294,000 in Q2 2017.
  • Its 3-year average for Change in Taxes is $3,000, with a median of $15,000 in 2017.
  • Per our database at Business Quant, Arbutus Biopharma's Change in Taxes surged by 66.21% in 2017 and then plummeted by 5,000.00% in 2019.
  • Quarterly analysis of 5 years shows Arbutus Biopharma's Change in Taxes stood at $164,000 in 2015, then decreased by 11.59% to $145,000 in 2016, then spiked by 66.21% to $241,000 in 2017, then crashed by 80.50% to $47,000 in 2018, then crashed by 5,000.00% to -$98,000 in 2019.
  • Its last three reported values are -$98,000 in Q1 2019, $47,000 for Q4 2018, and $2,000 during Q1 2018.